AI assistant
BIODESIX INC — Director's Dealing 2025
Nov 13, 2025
34472_dirs_2025-11-13_2830ea76-32aa-4a99-9099-91e86cbf29f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-11-10
Reporting Person: Pestano Gary Anthony (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | Common Stock | M | 69 | — | Acquired | 7962 | Direct |
| 2025-11-10 | Common Stock | S | 23 | $7.62 | Disposed | 7939 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | Restricted Stock Units | $ | M | 69 | Disposed | Common Stock (69) | Direct |
Footnotes
F1: These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
F2: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F3: These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F4: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.